Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.08
FSNUY's Cash to Debt is ranked higher than
53% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 0.21 vs. FSNUY: 0.08 )
FSNUY' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 0.08

Equity to Asset 0.39
FSNUY's Equity to Asset is ranked higher than
66% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. FSNUY: 0.39 )
FSNUY' s 10-Year Equity to Asset Range
Min: 0.18   Max: 0.42
Current: 0.39

0.18
0.42
Interest Coverage 4.27
FSNUY's Interest Coverage is ranked higher than
57% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.17 vs. FSNUY: 4.27 )
FSNUY' s 10-Year Interest Coverage Range
Min: 3.24   Max: 9999.99
Current: 4.27

3.24
9999.99
F-Score: 5
Z-Score: 1.54
M-Score: -2.43
WACC vs ROIC
4.17%
8.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 13.40
FSNUY's Operating margin (%) is ranked higher than
82% of the 346 Companies
in the Global Medical Care industry.

( Industry Median: 8.96 vs. FSNUY: 13.40 )
FSNUY' s 10-Year Operating margin (%) Range
Min: 11.06   Max: 15.67
Current: 13.4

11.06
15.67
Net-margin (%) 4.59
FSNUY's Net-margin (%) is ranked higher than
74% of the 346 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. FSNUY: 4.59 )
FSNUY' s 10-Year Net-margin (%) Range
Min: 1.63   Max: 7.54
Current: 4.59

1.63
7.54
ROE (%) 7.46
FSNUY's ROE (%) is ranked higher than
68% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 10.33 vs. FSNUY: 7.46 )
FSNUY' s 10-Year ROE (%) Range
Min: 7.11   Max: 14.75
Current: 7.46

7.11
14.75
ROA (%) 2.96
FSNUY's ROA (%) is ranked higher than
69% of the 351 Companies
in the Global Medical Care industry.

( Industry Median: 4.09 vs. FSNUY: 2.96 )
FSNUY' s 10-Year ROA (%) Range
Min: 1.33   Max: 5.42
Current: 2.96

1.33
5.42
ROC (Joel Greenblatt) (%) 32.56
FSNUY's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 17.65 vs. FSNUY: 32.56 )
FSNUY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 32.75   Max: 66.61
Current: 32.56

32.75
66.61
Revenue Growth (3Y)(%) 8.70
FSNUY's Revenue Growth (3Y)(%) is ranked higher than
76% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. FSNUY: 8.70 )
FSNUY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -44.6   Max: 10.5
Current: 8.7

-44.6
10.5
EBITDA Growth (3Y)(%) 5.80
FSNUY's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. FSNUY: 5.80 )
FSNUY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -48.9   Max: 24.5
Current: 5.8

-48.9
24.5
EPS Growth (3Y)(%) 11.90
FSNUY's EPS Growth (3Y)(%) is ranked higher than
76% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. FSNUY: 11.90 )
FSNUY' s 10-Year EPS Growth (3Y)(%) Range
Min: -35.7   Max: 34.9
Current: 11.9

-35.7
34.9
» FSNUY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with FSNUY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.50
FSNUY's P/E(ttm) is ranked higher than
78% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 56.80 vs. FSNUY: 28.50 )
FSNUY' s 10-Year P/E(ttm) Range
Min: 14.27   Max: 34.54
Current: 28.5

14.27
34.54
Forward P/E 4.79
FSNUY's Forward P/E is ranked higher than
99% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 4.79 )
N/A
PE(NRI) 29.10
FSNUY's PE(NRI) is ranked higher than
82% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 54.10 vs. FSNUY: 29.10 )
FSNUY' s 10-Year PE(NRI) Range
Min: 10.35   Max: 29.32
Current: 29.1

10.35
29.32
P/B 2.00
FSNUY's P/B is ranked higher than
83% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 3.60 vs. FSNUY: 2.00 )
FSNUY' s 10-Year P/B Range
Min: 0.41   Max: 3.06
Current: 2

0.41
3.06
P/S 1.28
FSNUY's P/S is ranked higher than
72% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 1.89 vs. FSNUY: 1.28 )
FSNUY' s 10-Year P/S Range
Min: 0.38   Max: 1.34
Current: 1.28

0.38
1.34
PFCF 24.20
FSNUY's PFCF is ranked higher than
79% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 116.67 vs. FSNUY: 24.20 )
FSNUY' s 10-Year PFCF Range
Min: 3.67   Max: 83.14
Current: 24.2

3.67
83.14
POCF 11.95
FSNUY's POCF is ranked higher than
83% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. FSNUY: 11.95 )
FSNUY' s 10-Year POCF Range
Min: 3.67   Max: 15.52
Current: 11.95

3.67
15.52
EV-to-EBIT 15.99
FSNUY's EV-to-EBIT is ranked higher than
85% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 30.31 vs. FSNUY: 15.99 )
FSNUY' s 10-Year EV-to-EBIT Range
Min: 3.5   Max: 16.4
Current: 15.99

3.5
16.4
PEG 4.16
FSNUY's PEG is ranked higher than
91% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 4.16 )
FSNUY' s 10-Year PEG Range
Min: 0.52   Max: 2.69
Current: 4.16

0.52
2.69
Shiller P/E 36.80
FSNUY's Shiller P/E is ranked higher than
80% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 36.80 )
FSNUY' s 10-Year Shiller P/E Range
Min: 14.65   Max: 37.81
Current: 36.8

14.65
37.81
Current Ratio 1.41
FSNUY's Current Ratio is ranked higher than
73% of the 333 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. FSNUY: 1.41 )
FSNUY' s 10-Year Current Ratio Range
Min: 1.13   Max: 1.56
Current: 1.41

1.13
1.56
Quick Ratio 1.08
FSNUY's Quick Ratio is ranked higher than
67% of the 333 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. FSNUY: 1.08 )
FSNUY' s 10-Year Quick Ratio Range
Min: 0.88   Max: 1.21
Current: 1.08

0.88
1.21
Days Inventory 49.63
FSNUY's Days Inventory is ranked higher than
71% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 42.45 vs. FSNUY: 49.63 )
FSNUY' s 10-Year Days Inventory Range
Min: 36.94   Max: 51.96
Current: 49.63

36.94
51.96
Days Sales Outstanding 67.10
FSNUY's Days Sales Outstanding is ranked higher than
63% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 54.36 vs. FSNUY: 67.10 )
FSNUY' s 10-Year Days Sales Outstanding Range
Min: 0.65   Max: 73.11
Current: 67.1

0.65
73.11

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.65
FSNUY's Dividend Yield is ranked lower than
76% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 1.48 vs. FSNUY: 0.65 )
FSNUY' s 10-Year Dividend Yield Range
Min: 0.73   Max: 2.22
Current: 0.65

0.73
2.22
Dividend Payout 0.14
FSNUY's Dividend Payout is ranked higher than
98% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 0.14 )
FSNUY' s 10-Year Dividend Payout Range
Min: 0.15   Max: 0.42
Current: 0.14

0.15
0.42
Dividend growth (3y) 13.30
FSNUY's Dividend growth (3y) is ranked higher than
78% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: 13.30 vs. FSNUY: 13.30 )
FSNUY' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 25.9
Current: 13.3

0
25.9
Yield on cost (5-Year) 1.45
FSNUY's Yield on cost (5-Year) is ranked higher than
53% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.75 vs. FSNUY: 1.45 )
FSNUY' s 10-Year Yield on cost (5-Year) Range
Min: 1.51   Max: 4.58
Current: 1.45

1.51
4.58
Share Buyback Rate -3.40
FSNUY's Share Buyback Rate is ranked higher than
66% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: -1.60 vs. FSNUY: -3.40 )
FSNUY' s 10-Year Share Buyback Rate Range
Min: -1.1   Max: -96.4
Current: -3.4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.10
FSNUY's Price/DCF (Projected) is ranked higher than
91% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 1.10 )
FSNUY' s 10-Year Price/DCF (Projected) Range
Min: 0.86   Max: 2.02
Current: 1.1

0.86
2.02
Price/Median PS Value 2.30
FSNUY's Price/Median PS Value is ranked higher than
50% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. FSNUY: 2.30 )
FSNUY' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 1.8
Current: 2.3

0.04
1.8
Price/Peter Lynch Fair Value 2.60
FSNUY's Price/Peter Lynch Fair Value is ranked higher than
90% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. FSNUY: 2.60 )
FSNUY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.66   Max: 2.02
Current: 2.6

0.66
2.02
Earnings Yield (Greenblatt) 6.40
FSNUY's Earnings Yield (Greenblatt) is ranked higher than
79% of the 340 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. FSNUY: 6.40 )
FSNUY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.1   Max: 28.6
Current: 6.4

6.1
28.6
Forward Rate of Return (Yacktman) 12.48
FSNUY's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 11.11 vs. FSNUY: 12.48 )
FSNUY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.5   Max: 31.4
Current: 12.48

0.5
31.4

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, BDUUF, SKHCY » details
Traded in other countries:0OO9.UK, FREN.Germany, 0QJF.UK, FRE.Switzerland, FRE.Germany,
Fresenius SE & Co KGaA is a health care company. It offers products and services for dialysis, hospitals, and outpatient medical care. It also manage projects and provide services for hospitals and other health care facilities worldwide. The Company's business segments are: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. Fresenius Medical Care offers products and services for patients with chronic kidney failure. Fresenius Kabi specializes in infusion therapies, intravenously administered drugs (IV drugs), and clinical nutrition. The company is also a supplier of medical devices and products in the area of transfusion technology. Fresenius Helios operated a total of 74 hospitals with more than 23,000 beds in Germany. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. The Company operates in about 80 countries through its subsidiaries.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK